Onconova Therapeutic
ONTX
Delayed Nasdaq - 10/20 10:00:00 pm
2.45USD
0%
Upcoming events

- No events available -

Past Events
10/19/17 | 08:30pmDawson James Small Cap Growth Stock Conference
10/17/17 | 11:45pmBIO Investor Forum
09/26/17Sachs Associates Biotech in Europe Investor Forum
09/12/17 | 03:35pmRodman & Renshaw Global Investment Conference
Annual results
Annual results20162017 (e)
Sales
Million $
Released
Forecast
Spread
5,55
6,37
-13%

0,84
Operating income (EBITDA)
Million $
Released
Forecast
Spread



-25,7
Operating profit (EBIT)
Million $
Released
Forecast
Spread
-23,7
-22,7
-4,6%

-26,1
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
-19,7
-19,7
0,01%

-26,2
Net income
Million $
Released
Forecast
Spread
-19,7
-19,7
-0,07%

-24,1
EPS
 $
Released
Forecast
Spread
-4,44
-0,59
-651%

-2,86
Announcement Date03/27/2017
Quarterly / Semiannualy publications
Quarterly resultsQ2
2017
Q3
2017 (e)
Sales
Million $
Released
Forecast
Spread
0,32
0,22
51%

0,15
Operating income (EBITDA)
Million $
Released
Forecast
Spread



-6,30
Operating profit (EBIT)
Million $
Released
Forecast
Spread
-6,07
-6,83
11%

-6,49
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
-2,58
-7,00
63%

-6,54
Net income
Million $
Released
Forecast
Spread
-2,58
-7,00
63%

-6,28
EPS
 $
Released
Forecast
Spread
-0,29
-0,72
60%

-0,68
Announcement Date08/15/2017
Net sales - Rate of surprise
Operating profit - Rate of surprise
EPS - Rate of surprise